Genscript Biotech Corporation (HKG:1548)

Genscript Biotech Statistics

Total Valuation

HKG:1548 has a market cap or net worth of HKD 30.06 billion. The enterprise value is 26.47 billion.

Market Cap	30.06B
Enterprise Value	26.47B

Important Dates

The last earnings date was Sunday, March 15, 2026.

Earnings Date	Mar 15, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:1548 has 2.19 billion shares outstanding. The number of shares has increased by 0.63% in one year.

Current Share Class	2.19B
Shares Outstanding	2.19B
Shares Change (YoY)	+0.63%
Shares Change (QoQ)	+3.33%
Owned by Insiders (%)	0.19%
Owned by Institutions (%)	17.07%
Float	1.38B

Valuation Ratios

PE Ratio	n/a
Forward PE	46.42
PS Ratio	4.03
PB Ratio	0.97
P/TBV Ratio	0.98
P/FCF Ratio	15.87
P/OCF Ratio	11.87
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.38
EV / Sales	3.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	13.97

Financial Position

The company has a current ratio of 1.50, with a Debt / Equity ratio of 0.09.

Current Ratio	1.50
Quick Ratio	1.35
Debt / Equity	0.09
Debt / EBITDA	1.05
Debt / FCF	1.42
Interest Coverage	14.76

Financial Efficiency

Return on equity (ROE) is -12.85% and return on invested capital (ROIC) is 7.30%.

Return on Equity (ROE)	-12.85%
Return on Assets (ROA)	3.15%
Return on Invested Capital (ROIC)	7.30%
Return on Capital Employed (ROCE)	6.18%
Weighted Average Cost of Capital (WACC)	8.82%
Revenue Per Employee	1.21M
Profits Per Employee	-672,709
Employee Count	6,165
Asset Turnover	0.19
Inventory Turnover	11.50

Taxes

In the past 12 months, HKG:1548 has paid 481.57 million in taxes.

Income Tax	481.57M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +32.12% in the last 52 weeks. The beta is 0.91, so HKG:1548's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	+32.12%
50-Day Moving Average	11.93
200-Day Moving Average	14.81
Relative Strength Index (RSI)	70.64
Average Volume (20 Days)	9,517,020

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1548 had revenue of HKD 7.47 billion and -4.15 billion in losses. Loss per share was -1.91.

Revenue	7.47B
Gross Profit	4.31B
Operating Income	1.99B
Pretax Income	-3.66B
Net Income	-4.15B
EBITDA	2.47B
EBIT	1.99B
Loss Per Share	-1.91

Balance Sheet

The company has 6.32 billion in cash and 2.68 billion in debt, with a net cash position of 3.64 billion or 1.66 per share.

Cash & Cash Equivalents	6.32B
Total Debt	2.68B
Net Cash	3.64B
Net Cash Per Share	1.66
Equity (Book Value)	30.86B
Book Value Per Share	14.10
Working Capital	2.79B

Cash Flow

In the last 12 months, operating cash flow was 2.53 billion and capital expenditures -639.29 million, giving a free cash flow of 1.89 billion.

Operating Cash Flow	2.53B
Capital Expenditures	-639.29M
Depreciation & Amortization	488.47M
Net Borrowing	601.11M
Free Cash Flow	1.89B
FCF Per Share	0.87

Margins

Gross margin is 57.65%, with operating and profit margins of 26.60% and -55.53%.

Gross Margin	57.65%
Operating Margin	26.60%
Pretax Margin	-49.04%
Profit Margin	-55.53%
EBITDA Margin	33.10%
EBIT Margin	26.60%
FCF Margin	25.37%

Dividends & Yields

HKG:1548 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.63%
Shareholder Yield	-0.63%
Earnings Yield	-13.79%
FCF Yield	6.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:1548 has an Altman Z-Score of 3.65 and a Piotroski F-Score of 6.

Altman Z-Score	3.65
Piotroski F-Score	6